Cohort study on pancreatic diseases in Toulouse

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients with various pancreatic diseases, excluding cancer, to develop diagnostic tools for differentiating between benign, potentially malignant, and malignant conditions. It involves the collection of clinical data and biological samples to enhance understanding and management of pancreatic pathologies. The study aims to improve monitoring and diagnostic performance for conditions such as acute and chronic pancreatitis and pancreatic cysts.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with inflammatory or cystic exocrine pancreatic pathology
* Patient able to read and understand the information leaflet
* Patients who have agreed to participate in the study and have signed the free and informed consent
* Patients affiliated to a social security system (including AME)

Exclusion Criteria:

* Patient with pancreatic cancer pathology
* Patients with active cancer, whatever the origin
* Pregnant or breastfeeding patients
* Patients under legal protection, guardianship or trusteeship

Where it's running

• Rangueil hospital
  Toulouse, France Recruiting

Study contacts

• Principal investigator: Barbara BOURNET, MD — University Hospital, Toulouse
• Study coordinator: Barbara BOURNET, MD
• Email: bournet.b@chu-toulouse.fr
• Phone: 0561323235

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Intensive 4-week postoperative multimodal rehab after proximal pancreatic surgery

  This study tests whether a 4-week multimodal rehabilitation program can help adults who have severe complications after proximal pancreatic surgery recover better.

  Recruiting IRCCS San Raffaele · Milan · NCT07768384

• New lipase NHS7108 safety and potential efficacy in adults with exocrine pancreatic insufficiency

  A 2-period study tests whether the new lipase NHS7108 works safely for adults with EPI by comparing it to the standard pancrelipase (Zenpep) at several doses over 14 days each.

  Recruiting at 7 sites Phase 2 Société des Produits Nestlé (SPN) · Scottsdale, Arizona and 38 other locations · NCT07559175

• Dabrafenib and trametinib for rare cancers with BRAF V600 mutations

  This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.

  Recruiting at 15 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT07440290

• Early diagnosis of pancreatic cancer using duodenal fluid biomarkers

  This project will see if pancreatic fluid collected during routine endoscopy can help detect early pancreatic cancer in adults.

  Recruiting at 3 sites Asan Medical Center · Aurora, Colorado and 2 other locations · NCT07030348

• Paracetamol with ibuprofen versus paracetamol with metamizole for pain in children with acute pancreatitis

  We will test whether IV paracetamol combined with ibuprofen or IV paracetamol combined with metamizole reduces pain more effectively in children aged 3–18 with acute pancreatitis.

  Recruiting Phase 4 Medical University of Warsaw · Warsaw · NCT07024199

• Using Ondansetron to Prevent Pancreatitis After ERCP

  This study is testing if the medication ondansetron can help prevent pancreatitis in adults who are having an ERCP procedure.

  Recruiting Phase 3 Tanta University · Tanta · NCT06861010

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.